The Cardiac Effects of COVID-19 on Young Competitive Athletes: Results from the Outcomes Registry for Cardiac Conditions in Athletes (ORCCA).
Fiche du document
6 février 2023
- doi: 10.3390/jcdd10020072
- issn: 2308-3425
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/doi/10.3390/jcdd10020072
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pmid/36826568
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/eissn/2308-3425
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_D204E0F4EA967
info:eu-repo/semantics/openAccess , CC BY 4.0 , https://creativecommons.org/licenses/by/4.0/
Sujets proches
Sports persons Sportspersons SportspeopleCiter ce document
N. Moulson et al., « The Cardiac Effects of COVID-19 on Young Competitive Athletes: Results from the Outcomes Registry for Cardiac Conditions in Athletes (ORCCA). », Serveur académique Lausannois, ID : 10.3390/jcdd10020072
Métriques
Partage / Export
Résumé
The Outcomes Registry for Cardiac Conditions in Athletes (ORCCA) study is a large-scale prospective investigation evaluating the cardiovascular effects and outcomes of SARS-CoV-2 infection on young competitive athletes. This review provides an overview of the key results from the ORCCA study. Results from the ORCCA study have provided important insights into the clinical impact of SARS-CoV-2 infection on the cardiovascular health of young competitive athletes and informed contemporary screening and return to sport practices. Key results include defining a low prevalence of both cardiac involvement and adverse cardiovascular outcomes after SARS-CoV-2 infection and evaluating the utility of a return-to-play cardiac evaluation. Future aims of the ORCCA study include the longer-term evaluation of cardiovascular outcomes among athletes post-SARS-CoV-2 infection and the transition to investigating outcomes in young athletes with potentially high-risk genetic or structural cardiac diagnoses.